Last update: Jan. 15, 2019
Minimal risk for breastfeeding and infant.
Glucocorticoid medication with topical opthalmic or dermatological use and with anti-inflammatory action, used in the form of 0.1% drops or ophthalmic ointment, or dermatological cream.
Indicated in cutaneous inflammation of the conjunctiva, the cornea and the anterior segment of the eye.
Since the last update we have not found published data on its excretion in breastmilk.
The small dose and low plasma absorption of most topical ophthalmological or dermatological preparations make it unlikely that significant amounts will transfer into breastmilk and for this reason it is considered to be compatible with breastfeeding (Briggs 2017).
In ophthalmic applications, it is possible to further decrease its absorption by pressing on the tear duct in the inner corner of the eye for 1 minute (IQB 2014).
We do not have alternatives for C05AA06; D07AB06; D10AA01; S01BA07 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2021 from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM